how is dr. lal pathlabs trading today?| bazaar corporate radar
Published 4 years ago • 296 plays • Length 9:05Download video MP4
Download video MP3
Similar videos
-
8:50
dr om manchanda on dr lal pathlabs' weak q3 earnings & outlook | bazaar corporate radar | cnbc-tv18
-
3:31
insight edge: dr lal pathlabs buzzing in trade after reports weak set of q4 numbers | cnbc-tv18
-
0:50
bull vs bear | contrasting brokerage views on dr lal path labs post q3 earnings | cnbc tv18
-
8:33
dr lal path labs' om manchanda speaks on q4 performance & fy24 margin outlook | cnbc-tv18
-
21:24
dr. lal pathlabs : healthy q3 | bazaar corporate radar | 9th feb 2018 | cnbc tv18
-
39:38
how to file taxes: tax expert demystifies the filing process | ibd
-
18:59
märkte im korrekturmodus: das sagen die charts zu dax, nvidia, gold & co.
-
10:42
anil singhvi in conversation with dr. om manchanda, managing director of dr lal pathlabs
-
7:40
dr lal pathlabs' bharath uppiliappan speaks on the firm's q2fy23 results | bazaar morning call
-
9:12
aspiration is to grow in double digit with margin at 26% in fy25: dr lal pathlabs | cnbc tv18
-
9:16
price increase is one of the reasons for the margin expansion: dr lal pathlabs | cnbc tv18
-
27:16
know all about dr lal path labs, srl diagnostics' ipo & apollo hospitals | the medicine box
-
1:42
what is the street expecting from dr lal pathlabs this q2?
-
16:02
dr lal pathlabs: earnings and future expansion plans | #battleforkarnataka | cnbc tv18
-
28:36
live | on the record: dr lal pathlabs | 75 years of legacy | exclusive | n18l | cnbc tv18
-
1:20
diagnostic companies: antique initiates sell on dr lal pathlabs & metropolis | trading hour
-
22:31
dr lal path labs, fortis healthcare & apollo; deep dive into key players of diagnostic business
-
1:24
goldman sachs downgrades dr lal pathlabs & metropolis healthcare to sell, slashes target price
-
10:12
diagnostics will continue to remain the mainstay within healthcare: dr lal path labs | cnbc tv18
-
16:07
dr lal path labs' om manchanda exclusive on the changing landscape of diagnostics | the medicine box
-
3:16
diagnostic stocks buzzing in trade ahead of india covid review meet today | bazaar corporate radar
-
2:02
dr lal pathlabs q2 results: margin at multi-quarter high, revenue per patient rises 8% | cnbc tv18